These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 25572692)

  • 1. Resveratrol nanoformulations: challenges and opportunities.
    Summerlin N; Soo E; Thakur S; Qu Z; Jambhrunkar S; Popat A
    Int J Pharm; 2015 Feb; 479(2):282-90. PubMed ID: 25572692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of resveratrol: What formulation solutions to bioavailability limitations?
    Amri A; Chaumeil JC; Sfar S; Charrueau C
    J Control Release; 2012 Mar; 158(2):182-93. PubMed ID: 21978644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from Conventional to Nano-natural Phytochemicals to Prevent and Treat Cancers: Special Emphasis on Resveratrol.
    Salman Ul Islam ; Ahmed MB; Mazhar Ul-Islam ; Shehzad A; Lee YS
    Curr Pharm Des; 2019; 25(34):3620-3632. PubMed ID: 31605574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol.
    Chauhan AS
    Ann N Y Acad Sci; 2015 Aug; 1348(1):134-40. PubMed ID: 26173478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol: review on therapeutic potential and recent advances in drug delivery.
    Pangeni R; Sahni JK; Ali J; Sharma S; Baboota S
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1285-98. PubMed ID: 24830814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New delivery systems to improve the bioavailability of resveratrol.
    Santos AC; Veiga F; Ribeiro AJ
    Expert Opin Drug Deliv; 2011 Aug; 8(8):973-90. PubMed ID: 21668403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Solid Dispersion System for Improving the Oral Bioavailability of Resveratrol in Rats.
    Chang CW; Wong CY; Wu YT; Hsu MC
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):239-249. PubMed ID: 27118361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity.
    Santos AC; Pereira I; Pereira-Silva M; Ferreira L; Caldas M; Collado-González M; Magalhães M; Figueiras A; Ribeiro AJ; Veiga F
    Colloids Surf B Biointerfaces; 2019 Aug; 180():127-140. PubMed ID: 31035056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS.
    Singh G; Pai RS
    J Control Release; 2014 Nov; 194():178-88. PubMed ID: 25217813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol-loaded nanomedicines for cancer applications.
    Annaji M; Poudel I; Boddu SHS; Arnold RD; Tiwari AK; Babu RJ
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1353. PubMed ID: 33655717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zein-Based Nanoparticles Improve the Oral Bioavailability of Resveratrol and Its Anti-inflammatory Effects in a Mouse Model of Endotoxic Shock.
    Penalva R; Esparza I; Larraneta E; González-Navarro CJ; Gamazo C; Irache JM
    J Agric Food Chem; 2015 Jun; 63(23):5603-11. PubMed ID: 26027429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol nanoformulation for cancer prevention and therapy.
    Siddiqui IA; Sanna V; Ahmad N; Sechi M; Mukhtar H
    Ann N Y Acad Sci; 2015 Aug; 1348(1):20-31. PubMed ID: 26109073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
    Lin HS; Ho PC
    J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro-in vivo characterization of trans-resveratrol nanosuspensions.
    Dong Q; Yuan HL; Qian JJ; Zhang CY; Chen WD
    Biomed Mater Eng; 2018; 29(3):333-345. PubMed ID: 29578462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
    Singh G; Pai RS
    J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach.
    Soo E; Thakur S; Qu Z; Jambhrunkar S; Parekh HS; Popat A
    J Colloid Interface Sci; 2016 Jan; 462():368-74. PubMed ID: 26479200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol.
    Augustin MA; Sanguansri L; Lockett T
    Ann N Y Acad Sci; 2013 Jul; 1290():107-12. PubMed ID: 23855472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of
    Scalia S; Zampino MR; Trotta V; Bianchi A
    Pharmazie; 2017 Apr; 72(4):200-204. PubMed ID: 29441987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Topical Delivery of Resveratrol through a Nanosizing Approach.
    Sinico C; Pireddu R; Pini E; Valenti D; Caddeo C; Fadda AM; Lai F
    Planta Med; 2017 Mar; 83(5):476-481. PubMed ID: 27220078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective.
    Ratnam DV; Ankola DD; Bhardwaj V; Sahana DK; Kumar MN
    J Control Release; 2006 Jul; 113(3):189-207. PubMed ID: 16790290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.